MS
Therapeutic Areas
Synthaverse Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ONKO BCG ® 50 | Oncological immunotherapy (likely bladder cancer) | Approved |
| ONKO BCG ® 100 | Oncological immunotherapy (likely bladder cancer) | Approved |
| GAMMA ANTY-D ® 50 | Immunotherapy in serological conflict (e.g., Rh disease) | Approved |
| GAMMA ANTY-D ® 150 | Immunotherapy in serological conflict (e.g., Rh disease) | Approved |
| GAMMA ® ANTY HBS 200 | Passive immunotherapy in hepatitis B | Approved |
| BCG10 | Active anti-tuberculosis immunotherapy (Vaccine) | Approved |
| Distreptaza ® | Gynecology and proctology | Approved |
| LACTOBACILLUS - LAKCID ® | Probiotics | Approved |